Literature DB >> 15908417

Contribution of nitric oxide to CpG-mediated protection against Listeria monocytogenes.

Shuichi Ito1, Ken J Ishii, Atsushi Ihata, Dennis M Klinman.   

Abstract

Immunostimulatory CpG oligodeoxynucleotides (ODN) improve host resistance to listeriae. CpG ODN trigger immune cells to produce gamma interferon and "prime" host cells to secrete nitric oxide in response to bacterial exposure. CpG treatment does not protect inducible nitric oxide synthase 2 knockout mice, indicating that NO is critical to CpG-mediated protection against listeriae.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15908417      PMCID： PMC1111823          DOI： 10.1128/IAI.73.6.3803-3805.2005

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  22 in total

1.  Cutting edge: bacterial DNA and LPS act in synergy in inducing nitric oxide production in RAW 264.7 macrophages.

Authors:  J J Gao; E G Zuvanich; Q Xue; D L Horn; R Silverstein; D C Morrison
Journal:  J Immunol       Date:  1999-10-15       Impact factor: 5.422

2.  A Toll-like receptor recognizes bacterial DNA.

Authors:  H Hemmi; O Takeuchi; T Kawai; T Kaisho; S Sato; H Sanjo; M Matsumoto; K Hoshino; H Wagner; K Takeda; S Akira
Journal:  Nature       Date:  2000-12-07       Impact factor: 49.962

3.  Repeated administration of synthetic oligodeoxynucleotides expressing CpG motifs provides long-term protection against bacterial infection.

Authors:  D M Klinman; J Conover; C Coban
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

Review 4.  Immune responses to intracellular bacteria.

Authors:  B Raupach; S H Kaufmann
Journal:  Curr Opin Immunol       Date:  2001-08       Impact factor: 7.486

Review 5.  Listeria pathogenesis and molecular virulence determinants.

Authors:  J A Vázquez-Boland; M Kuhn; P Berche; T Chakraborty; G Domínguez-Bernal; W Goebel; B González-Zorn; J Wehland; J Kreft
Journal:  Clin Microbiol Rev       Date:  2001-07       Impact factor: 26.132

6.  CpG oligodeoxynucleotides enhance host defense during murine tuberculosis.

Authors:  Nicole P Juffermans; Jaklien C Leemans; Sandrine Florquin; Annelies Verbon; Arend H Kolk; Peter Speelman; Sander J H van Deventer; Tom van der Poll
Journal:  Infect Immun       Date:  2002-01       Impact factor: 3.441

7.  Use of immunostimulatory sequence-containing oligonucleotides as topical therapy for genital herpes simplex virus type 2 infection.

Authors:  Richard B Pyles; Debbie Higgins; Claudia Chalk; Anthony Zalar; Joseph Eiden; Carrie Brown; Gary Van Nest; Lawrence R Stanberry
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

8.  Cutting edge: Role of Toll-like receptor 9 in CpG DNA-induced activation of human cells.

Authors:  F Takeshita; C A Leifer; I Gursel; K J Ishii; S Takeshita; M Gursel; D M Klinman
Journal:  J Immunol       Date:  2001-10-01       Impact factor: 5.422

9.  Host response to infection: the role of CpG DNA in induction of cyclooxygenase 2 and nitric oxide synthase 2 in murine macrophages.

Authors:  D K Ghosh; M A Misukonis; C Reich; D S Pisetsky; J B Weinberg
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

10.  Interleukin-12- and gamma interferon-dependent protection against malaria conferred by CpG oligodeoxynucleotide in mice.

Authors:  R A Gramzinski; D L Doolan; M Sedegah; H L Davis; A M Krieg; S L Hoffman
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441
View more
  3 in total

1.  Molecular chaperoning by glucose-regulated protein 170 in the extracellular milieu promotes macrophage-mediated pathogen sensing and innate immunity.

Authors:  Daming Zuo; Xiaofei Yu; Chunqing Guo; Huanfa Yi; Xing Chen; Daniel H Conrad; Tai L Guo; Zhengliang Chen; Paul B Fisher; John R Subjeck; Xiang-Yang Wang
Journal:  FASEB J       Date:  2011-12-29       Impact factor: 5.191

2.  Inhibitory/suppressive oligodeoxynucleotide nanocapsules as simple oral delivery devices for preventing atopic dermatitis in mice.

Authors:  Yeqin Wang; Yoshinari Yamamoto; Suguru Shigemori; Takafumi Watanabe; Kazushi Oshiro; Xinyu Wang; Pengfei Wang; Takashi Sato; Shinichi Yonekura; Sachi Tanaka; Haruki Kitazawa; Takeshi Shimosato
Journal:  Mol Ther       Date:  2014-12-15       Impact factor: 11.454

3.  Systemic treatment with CpG-B after sublethal rickettsial infection induces mouse death through indoleamine 2,3-dioxygenase (IDO).

Authors:  Lijun Xin; Thomas R Shelite; Bin Gong; Nicole L Mendell; Lynn Soong; Rong Fang; David H Walker
Journal:  PLoS One       Date:  2012-03-28       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.